JP2000511511A - 腫瘍成長阻害及び毛細管増殖のための生物学的活性タンパク質、コラーゲンフラグメントＨＦ―ＣＯＬＬ―１８／５１４ｃｆ - Google Patents

腫瘍成長阻害及び毛細管増殖のための生物学的活性タンパク質、コラーゲンフラグメントＨＦ―ＣＯＬＬ―１８／５１４ｃｆ

Info

Publication number
JP2000511511A
JP2000511511A JP09537737A JP53773797A JP2000511511A JP 2000511511 A JP2000511511 A JP 2000511511A JP 09537737 A JP09537737 A JP 09537737A JP 53773797 A JP53773797 A JP 53773797A JP 2000511511 A JP2000511511 A JP 2000511511A
Authority
JP
Japan
Prior art keywords
coll
treatment
fragment
diseases
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP09537737A
Other languages
English (en)
Japanese (ja)
Inventor
ボルフ―ゲオルグ フォースマン
ミカエル シュレイダー
ルートガー スタントカー
マンフレッド ライダ
ペーター シュルツ―ナッペ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2000511511A publication Critical patent/JP2000511511A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP09537737A 1996-04-22 1997-04-22 腫瘍成長阻害及び毛細管増殖のための生物学的活性タンパク質、コラーゲンフラグメントＨＦ―ＣＯＬＬ―１８／５１４ｃｆ Ceased JP2000511511A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19615710.2 1996-04-22
DE19615710A DE19615710A1 (de) 1996-04-22 1996-04-22 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose
PCT/EP1997/002012 WO1997040073A2 (de) 1996-04-22 1997-04-22 BIOLOGISCH AKTIVER EIWEISSSTOFF - KOLLAGENFRAGMENT HF-COLL-18/514cf - ZUR HEMMUNG DES WACHSTUMS VON TUMOREN UND VON GEFÄSSWUCHERUNGEN

Publications (1)

Publication Number Publication Date
JP2000511511A true JP2000511511A (ja) 2000-09-05

Family

ID=7791888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09537737A Ceased JP2000511511A (ja) 1996-04-22 1997-04-22 腫瘍成長阻害及び毛細管増殖のための生物学的活性タンパク質、コラーゲンフラグメントＨＦ―ＣＯＬＬ―１８／５１４ｃｆ

Country Status (5)

Country Link
EP (1) EP0896584A2 (de)
JP (1) JP2000511511A (de)
AU (1) AU2766597A (de)
DE (1) DE19615710A1 (de)
WO (1) WO1997040073A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004050125A1 (ja) * 2002-12-03 2004-06-17 Koken Co.,Ltd. 腫瘍細胞の増殖及び／又は浸潤の抑制剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048924A1 (en) * 1998-03-24 1999-09-30 The Children's Medical Center Corporation Endostatin derived peptides with anti-angiogenic and anti-cancer activity
WO2000017240A1 (de) * 1998-09-21 2000-03-30 Haemopep Pharma Gmbh Hmw-endostatin zur hemmung des wachstums von tumoren und von gefässwucherungen und zur diagnose von gefäss- und tumorerkrankungen
ITMI20010394A1 (it) * 2001-02-27 2002-08-27 Univ Degli Studi Milano Peptidi ad attivita' antiangiogenica
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633797C2 (de) * 1986-10-03 1995-08-10 Forssmann Wolf Georg Verfahren zur Gewinnung von biologisch aktiven Eiweissen (Peptiden) aus menschlichem und tierischem Blut (bzw. anderen Körperflüssigkeiten)
WO1993016716A1 (en) * 1992-02-24 1993-09-02 Northwestern University Method and composition for inhibiting angiogenesis
BR9611174A (pt) * 1995-10-23 1999-09-14 Childrens Medical Center Proteína de endostatina isolada, e composições terapêuticas antiangiogénicas formadas com a mesma.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004050125A1 (ja) * 2002-12-03 2004-06-17 Koken Co.,Ltd. 腫瘍細胞の増殖及び／又は浸潤の抑制剤
JPWO2004050125A1 (ja) * 2002-12-03 2006-03-30 株式会社高研 腫瘍細胞の増殖及び／又は浸潤の抑制剤

Also Published As

Publication number Publication date
EP0896584A2 (de) 1999-02-17
WO1997040073A2 (de) 1997-10-30
DE19615710A1 (de) 1997-10-23
WO1997040073A3 (de) 1997-12-24
AU2766597A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
EP2552470B1 (de) Peptide zur angiogeneseförderung und verwendung davon
CA2071538C (en) Hpth (1-37) fragment, its production, drug containing it and its use
JP2022551153A (ja) 活性ポリペプチド化合物
JP2819467B2 (ja) 新規なカルジオジラチン断片およびその製造方法
US6262024B1 (en) Neuron regulatory factor for promoting neuron survival
HK30289A (en) Pharmaceutical composition comprising phenyl acetyl glutamine, a combination of this compound with phenylacetic acid or 3-(phenylacetylamino)piperidine-2, 6-dione, a process for isolating the latter from urine and a process for the synthesis of 3-(phenylacetylamino)piperidine-2, 6-dione
KR20180043428A (ko) 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
JPH06228199A (ja) 血液脳関門通過可能なペプチド結合体
CN107629114B (zh) 多肽、其衍生物及其在制备抗肺纤维化的药物中的应用
EP1008603B1 (de) Lösliche Polypeptide bestehend aus der ersten Coiled coil Domäne aus Mensch- und Maus-Epimorphin
JPH08509960A (ja) 骨原性成長オリゴペプチドおよびそれを含む医薬組成物
JP2000511511A (ja) 腫瘍成長阻害及び毛細管増殖のための生物学的活性タンパク質、コラーゲンフラグメントＨＦ―ＣＯＬＬ―１８／５１４ｃｆ
EP2963053A1 (de) Peptide zur angiogeneseförderung und verwendung davon
CN113024635B (zh) 一类订书肽化合物及其药物组合物的用途
JP2002500161A (ja) 神経栄養性および鎮痛性のレトロインバースペプチド
US6096706A (en) Growth-promoting proteins and peptides for kidney epithelial cells
US4559325A (en) Purified antineoplaston fractions and methods of treating neoplastic disease
US7550438B2 (en) Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
EP3333177B1 (de) Multitarget-verbindung mit antikoagulations- und thrombozytenaggregationshemmender wirkung, herstellungsverfahren dafür und verwendung davon
JP2002509693A (ja) カドヘリン由来成長因子及びその使用
EP2234632B1 (de) Proteinöse verbindungen
JP4168623B2 (ja) オリゴペプチド
CN117229384A (zh) 新型生长激素释放激素类似肽单体、二聚体或四聚体及其制备和应用
WO2008050161A2 (en) Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
JPH03170498A (ja) ペプチドおよびこのペプチドを含有する薬剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060822

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070220